Literature DB >> 34430532

Trends in the use of adjuvant therapy for resected intrahepatic cholangiocarcinoma: getting ahead of the data.

Jordan M Cloyd1, Timothy M Pawlik1.   

Abstract

Entities:  

Year:  2021        PMID: 34430532      PMCID: PMC8351004          DOI: 10.21037/hbsn-2021-12

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN: 2304-3881            Impact factor:   7.293


× No keyword cloud information.
  13 in total

Review 1.  Cholangiocarcinoma 2020: the next horizon in mechanisms and management.

Authors:  Jesus M Banales; Jose J G Marin; Angela Lamarca; Pedro M Rodrigues; Shahid A Khan; Lewis R Roberts; Vincenzo Cardinale; Guido Carpino; Jesper B Andersen; Chiara Braconi; Diego F Calvisi; Maria J Perugorria; Luca Fabris; Luke Boulter; Rocio I R Macias; Eugenio Gaudio; Domenico Alvaro; Sergio A Gradilone; Mario Strazzabosco; Marco Marzioni; Cédric Coulouarn; Laura Fouassier; Chiara Raggi; Pietro Invernizzi; Joachim C Mertens; Anja Moncsek; Sumera Rizvi; Julie Heimbach; Bas Groot Koerkamp; Jordi Bruix; Alejandro Forner; John Bridgewater; Juan W Valle; Gregory J Gores
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-06-30       Impact factor: 46.802

2.  Advances in the Diagnosis and Treatment of Patients with Intrahepatic Cholangiocarcinoma.

Authors:  Aslam Ejaz; Jordan M Cloyd; Timothy M Pawlik
Journal:  Ann Surg Oncol       Date:  2019-09-25       Impact factor: 5.344

3.  Randomized clinical trial of adjuvant gemcitabine chemotherapy versus observation in resected bile duct cancer.

Authors:  T Ebata; S Hirano; M Konishi; K Uesaka; Y Tsuchiya; M Ohtsuka; Y Kaneoka; M Yamamoto; Y Ambo; Y Shimizu; F Ozawa; A Fukutomi; M Ando; Y Nimura; M Nagino
Journal:  Br J Surg       Date:  2018-02       Impact factor: 6.939

4.  Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study.

Authors:  John N Primrose; Richard P Fox; Daniel H Palmer; Hassan Z Malik; Raj Prasad; Darius Mirza; Alan Anthony; Pippa Corrie; Stephen Falk; Meg Finch-Jones; Harpreet Wasan; Paul Ross; Lucy Wall; Jonathan Wadsley; Jeff T R Evans; Deborah Stocken; Raaj Praseedom; Yuk Ting Ma; Brian Davidson; John P Neoptolemos; Tim Iveson; James Raftery; Shihua Zhu; David Cunningham; O James Garden; Clive Stubbs; Juan W Valle; John Bridgewater
Journal:  Lancet Oncol       Date:  2019-03-25       Impact factor: 41.316

5.  Lymphadenectomy for Intrahepatic Cholangiocarcinoma: Has Nodal Evaluation Been Increasingly Adopted by Surgeons over Time?A National Database Analysis.

Authors:  Xu-Feng Zhang; Qinyu Chen; Charles W Kimbrough; Eliza W Beal; Yi Lv; Jeffery Chakedis; Mary Dillhoff; Carl Schmidt; Jordan Cloyd; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2017-12-20       Impact factor: 3.452

6.  Adjuvant chemotherapy for intrahepatic cholangiocarcinoma: approaching clinical practice consensus?

Authors:  Ariella M Altman; Scott Kizy; Schelomo Marmor; Jane Y C Hui; Todd M Tuttle; Eric H Jensen; Jason W Denbo
Journal:  Hepatobiliary Surg Nutr       Date:  2020-10       Impact factor: 7.293

7.  Gemcitabine and Oxaliplatin Chemotherapy or Surveillance in Resected Biliary Tract Cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): A Randomized Phase III Study.

Authors:  Julien Edeline; Meher Benabdelghani; Aurélie Bertaut; Jérôme Watelet; Pascal Hammel; Jean-Paul Joly; Karim Boudjema; Laetitia Fartoux; Karine Bouhier-Leporrier; Jean-Louis Jouve; Roger Faroux; Véronique Guerin-Meyer; Jean-Emmanuel Kurtz; Eric Assénat; Jean-François Seitz; Isabelle Baumgaertner; David Tougeron; Christelle de la Fouchardière; Catherine Lombard-Bohas; Eveline Boucher; Trevor Stanbury; Christophe Louvet; David Malka; Jean-Marc Phelip
Journal:  J Clin Oncol       Date:  2019-02-01       Impact factor: 44.544

8.  The Landmark Series: Intrahepatic Cholangiocarcinoma.

Authors:  Jordan M Cloyd; Aslam Ejaz; Timothy M Pawlik
Journal:  Ann Surg Oncol       Date:  2020-05-17       Impact factor: 5.344

9.  Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice Guideline.

Authors:  Rachna T Shroff; Erin B Kennedy; Melinda Bachini; Tanios Bekaii-Saab; Christopher Crane; Julien Edeline; Anthony El-Khoueiry; Mary Feng; Matthew H G Katz; John Primrose; Heloisa P Soares; Juan Valle; Shishir K Maithel
Journal:  J Clin Oncol       Date:  2019-03-11       Impact factor: 50.717

Review 10.  Neoadjuvant treatment strategies for intrahepatic cholangiocarcinoma.

Authors:  Clifford Akateh; Aslam M Ejaz; Timothy Michael Pawlik; Jordan M Cloyd
Journal:  World J Hepatol       Date:  2020-10-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.